An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis

被引:95
|
作者
Adeloye, Davies [1 ,2 ,3 ,4 ]
David, Rotimi Adedeji [5 ]
Aderemi, Adewale Victor [6 ]
Iseolorunkanmi, Alexander [7 ]
Oyedokun, Ayo [8 ]
Iweala, Emeka E. J. [9 ]
Omoregbe, Nicholas [2 ,10 ]
Ayo, Charles K. [2 ,10 ]
机构
[1] Covenant Univ, Demog & Social Stat, PMB 1023, Ota, Ogun State, Nigeria
[2] Covenant Univ, E Hlth Res Cluster, PMB 1023, Ota, Ogun State, Nigeria
[3] Univ Edinburgh, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland
[4] Univ Edinburgh, World Hlth Org Collaborating Ctr Populat Hlth Res, Usher Inst, Edinburgh, Midlothian, Scotland
[5] Obafemi Awolowo Univ, Dept Surg, Teaching Hosp Complex, Ife, Nigeria
[6] Osun State Univ, Dept Biochem, Coll Hlth Sci, Osogbo, Nigeria
[7] Covenant Univ, Univ Hlth Ctr, Ota, Nigeria
[8] St Nicholas Hosp, Lagos, Nigeria
[9] Covenant Univ, Dept Biol Sci, PMB 1023, Ota, Ogun State, Nigeria
[10] Covenant Univ, Dept Comp & Informat Sci, PMB 1023, Ota, Ogun State, Nigeria
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
TARGETED THERAPY; PALLIATIVE CARE; EASTERN LIBYA; SOUTH-AFRICA; POPULATION; MORTALITY; BURDEN; REGISTRY; TRENDS; EPIDEMIOLOGY;
D O I
10.1371/journal.pone.0153496
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Prostate cancer (PCa) is rated the second most common cancer and sixth leading cause of cancer deaths among men globally. Reports show that African men suffer disproportionately from PCa compared to men from other parts of the world. It is still quite difficult to accurately describe the burden of PCa in Africa due to poor cancer registration systems. We systematically reviewed the literature on prostate cancer in Africa and provided a continent-wide incidence rate of PCa based on available data in the region. Methods A systematic literature search of Medline, EMBASE and Global Health from January 1980 to June 2015 was conducted, with additional search of Google Scholar, International Association of Cancer Registries (IACR), International Agency for Research on Cancer (IARC), and WHO African region websites, for studies that estimated incidence rate of PCa in any African location. Having assessed quality and consistency across selected studies, we extracted incidence rates of PCa and conducted a random effects meta-analysis. Results Our search returned 9766 records, with 40 studies spreading across 16 African countries meeting our selection criteria. We estimated a pooled PCa incidence rate of 22.0 (95% CI: 19.93-23.97) per 100,000 population, and also reported a median incidence rate of 19.5 per 100,000 population. We observed an increasing trend in PCa incidence with advancing age, and over the main years covered. Conclusion Effective cancer registration and extensive research are vital to appropriately quantifying PCa burden in Africa. We hope our findings may further assist at identifying relevant gaps, and contribute to improving knowledge, research, and interventions targeted at prostate cancer in Africa.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] THE INCIDENCE OF BLADDER CANCER IN IRAN: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hassanipour, S.
    Delam, H.
    Fathalipour, M.
    Sharifi, M.
    Abdzadeh, E.
    Fouladseresht, H.
    Riahi, S.
    Salehiniya, H.
    Arab-Zozani, M.
    [J]. WORLD CANCER RESEARCH JOURNAL, 2019, 6
  • [22] The Incidence of Childhood Cancer in Iran: A systematic review and meta-analysis
    Hassanipour, Soheil
    Fathalipour, Mohammad
    Delam, Hamed
    Ghorbani, Mohammad
    Abdzadeh, Elham
    Arab-Zozani, Morteza
    Riahi, Shirin
    Salehiniya, Hamid
    [J]. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 9 (03) : 193 - 206
  • [23] The Incidence of Esophageal Cancer in Iran: A Systematic Review and Meta-analysis
    Salehiniya, Hamid
    Hassanipour, Soheil
    Mansour-Ghanaei, Fariborz
    Mohseni, Shokrollah
    Joukar, Farahnaz
    Abdzadeh, Elham
    Fathalipour, Mohammad
    Arab-Zozani, Morteza
    [J]. BIOMEDICAL RESEARCH AND THERAPY, 2018, 5 (07): : 2493 - 2503
  • [24] Hypertension and risk of prostate cancer: a systematic review and meta-analysis
    Zhen Liang
    Bo Xie
    Jiangfeng Li
    Xiao Wang
    Song Wang
    Shuai Meng
    Alin Ji
    Yi Zhu
    Xin Xu
    Xiangyi Zheng
    Liping Xie
    [J]. Scientific Reports, 6
  • [25] PET/MRI in prostate cancer: a systematic review and meta-analysis
    Evangelista, Laura
    Zattoni, Fabio
    Cassarino, Gianluca
    Artioli, Paolo
    Cecchin, Diego
    dal Moro, Fabrizio
    Zucchetta, Pietro
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (03) : 859 - 873
  • [26] Human papillomavirus and prostate cancer: systematic review and meta-analysis
    Irina A. Tsydenova
    Marina K. Ibragimova
    Matvey M. Tsyganov
    Nikolai V. Litviakov
    [J]. Scientific Reports, 13
  • [27] Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
    Baboudjian, Michael
    Rajwa, Pawel
    Barret, Eric
    Beauval, Jean-Baptiste
    Brureau, Laurent
    Crehange, Gilles
    Dariane, Charles
    Fiard, Gaelle
    Fromont, Gaelle
    Gauthe, Mathieu
    Mathieu, Romain
    Renard-Penna, Raphaele
    Roubaud, Guilhem
    Ruffion, Alain
    Sargos, Paul
    Roupret, Morgan
    Ploussard, Guillaume
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2022, 41 : 35 - 44
  • [28] The prevalence of prostate cancer in Pakistan: A systematic review and meta-analysis
    Akhtar, Sohail
    Hassan, Fazal
    Ahmad, Sadique
    El-Affendi, Mohammed A.
    Khan, Muhammad Imran
    [J]. HELIYON, 2023, 9 (10)
  • [29] Photodynamic therapy for prostate cancer: a systematic review and meta-analysis
    Wang, Lang
    Yang, Hanfeng
    Li, Bing
    [J]. PROSTATE INTERNATIONAL, 2019, 7 (03) : 83 - 90
  • [30] Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis
    Bourke, Liam
    Smith, Dianna
    Steed, Liz
    Hooper, Richard
    Carter, Anouska
    Catto, James
    Albertsen, Peter C.
    Tombal, Bertrand
    Payne, Heather A.
    Rosario, Derek J.
    [J]. EUROPEAN UROLOGY, 2016, 69 (04) : 693 - 703